Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 10144840300

Biography

Personal Statement
I am an academic gastroenterologist with a special interest in the clinical management of Inflammatory Bowel Disease (IBD). My primary research aim is optimising advanced imaging techniques aimed at measuring inflammation and fibrosis in IBD. I am the clinical lead of the Simple Trials in Applied Research team within Nottingham Clinical trials Unit. We specialise in delivering large pragmatic trials in primary care using routinely collected coded data sets. Together with collaborators at the University of Nottingham we create large deeply phenotypes cohorts. I specialise in the design and delivery of phase 3/4 clinical trials.
I am the lead author of the BSG IBD guidelines for 2025.
I presently supervise 5 PhD students, 2 post-doctoral scientist and 1 IBD fellows. I am the academic and clinical IBD theme lead within the NIHR Nottingham Biomedical Research Centre and IBD Section Committee Member for the British Society of Gastroenterology and IBD expert member for the National Institute of Health Research Trent Clinical Research Network.

Activities

Collapse all

Employment (1)

University of Nottingham: Nottingham, Nottingham, GB

2013-10-01 to present (Nottingham Digestive Disease Centre)
Employment
Source: Self-asserted source
Gordon Moran

Education and qualifications (2)

Royal college of Physicians: London, GB

2019-07-02 to present | FRCP
Qualification
Source: Self-asserted source
Gordon Moran

University of Nottingham: Nottingham, Nottinghamshire, GB

2013-10-01 to present | MD, MRCP, PGCertMedEd, PhD (NIHR Nottingham Biomedical Research Centre)
Education
Source: Self-asserted source
Gordon Moran

Professional activities (6)

Nutrients Journal: N/A, CN

Editorial Board
Invited position
Source: Self-asserted source
Gordon Moran

National Institute for Health Research: Trent region, GB

Membership
Source: Self-asserted source
Gordon Moran

Journal of Crohn's and Colitis: N/A, AT

Editorial Board member
Invited position
Source: Self-asserted source
Gordon Moran

European Crohn's and Colitis Organisation: Vienna, AT

Membership
Source: Self-asserted source
Gordon Moran

Cochrane Gut: UK, GB

Editorial Board
Invited position
Source: Self-asserted source
Gordon Moran

British Society of Gastroenterology: London, London, GB

Membership
Source: Self-asserted source
Gordon Moran

Funding (41)

STOpping PpI Therapy in inactive IBD Study (STOP-IT): A feasibility study

2025-05 to 2028-04 | Grant
NIHR (London, GB)
Source: Self-asserted source
Gordon Moran

A description of the clinical burden and drug class outcomes of Ulcerative Proctitis (UP) using the National Institute for health and Care Research (NIHR) Inflammatory Bowel Disease (IBD) Bioresource

2024-09 to 2025-03 | Grant
Pfizer Limited (Tadworth, GB)
Source: Self-asserted source
Gordon Moran

MagnetiC ResOnance ImagiNg of intrabdominal lymphatiCs and vasculaturE as measures of disease activity in Ozanimod-treated patients with active UlceratIVE Colitis (CONCEIVE)

2023-11 to 2027-06 | Award
Bristol-Myers Squibb (NY, NY, US)
Source: Self-asserted source
Gordon Moran

A feasibility study to assess a "Virtual" (v)EUA Technology to Improve the management of perianal Crohn’s disease

2023-06 to 2025-06 | Grant
Crohn's and Colitis UK (London, GB)
Source: Self-asserted source
Gordon Moran

The long-term impact of non-response to small molecule drugs and biological therapies in Inflammatory Bowel Disease: a UK nation-wide analysis through the NIHR IBD Bioresource

2023-03 to 2024-03 | Award
Janssen Pharmaceuticals (NJ, NJ, US)
Source: Self-asserted source
Gordon Moran

Identifying a WNT pathway inhibitor for stem cell maintenance in IBD

2022-12 to 2025-12 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Gordon Moran

MINIGUTS: Development of novel in vitro models of adult and paediatric IBD

2022-12 to 2024-06 | Grant
Guts UK Charity (London, GB)
Source: Self-asserted source
Gordon Moran

Understanding how immune dysfunction impacts ulcerative colitis using human mini colons

2022-01 to 2024-01 | Grant
Bowel Research UK (London, GB)
Source: Self-asserted source
Gordon Moran

DEMISTIFI Multi Morbidity: DEfining MechanIsms Shared across mulTI-organ FIbrotic disease to prevent the development of long term multi-morbidity (

2021-12 to 2025-12 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Gordon Moran

Nottingham/Astra ZenecA prospective IBD cohort study

2021-12 to 2024-06 | Grant
Astra Zeneca (Sweden, SE)
Source: Self-asserted source
Gordon Moran

Stopping Aminosalicylate Therapy in Inactive Crohn’s Disease Study: A Randomized, Open-label, Non-inferiority

2021-01 to 2025-12 | Grant
Alimentiv Inc (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Targeting a Cxcl10-approach in Ulcerative Colitis

2021-01 to 2022-10 | Grant
CICRA (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

The MERIT pilot study: Towards Precision Medicine: a MagnEtic Resonance Imaging-based measure of fibrosis in enTeric Crohn’s disease

2021-01 to 2022-04 | Award
Medical Research Council (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Deep Nutritional Phenotyping of Crohn’s Patients with Sarcopenia

2020-04 to 2022-03 | Grant
NIHR Nottingham Biomedical Research Centre (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Feasibility of a quantitative MRI protocol for the assessment of inflammation in Ulcerative Colitis

2020-04 to 2022-03 | Grant
NIHR Nottingham Biomedical research Centre (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Real World Evidence Driving Changes in Crohn’s Disease Management Using Quantitative Imaging Analysis

2020-04 to 2022-03 | Grant
NIHR i4i (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Defining MechanIsms Shared across mulTI-organ Fibrotic disease to prevent the development of long term multi-morbidity

2020-02 to 2021-02 | Grant
Medical Research Council (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomes

2020-01 to 2022-09 | Grant
Innovate UK (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

STATIC

2019-01 to 2022-01 | Grant
Rosetrees Trust (London, GB)
Source: Self-asserted source
Gordon Moran

MRI changes in visceral fat in Crohn’s Disease (PI)

2019-01 to 2020-12 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Gordon Moran

STATIC

2019-01 to 2020-12 | Grant
Nottingham University Hospitals NHS Trust (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Stopping Aminosalicylate Therapy in Inactive Crohn’s Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority (STATIC)

2019-01 to 2020-12 | Grant
European Crohn's and Colitis Organisation - ECCO (Vienna, AT)
Source: Self-asserted source
Gordon Moran

Education Grant

2019-01 to 2019-12 | Grant
Phebra Ltd (Richmond, AU)
Source: Self-asserted source
Gordon Moran

Development of MR Elastography of the Bowel (DOME)

2018-09 to 2021-07 | Grant
Hayden Green PhD Studentship (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Non-invasive approaches to identify the cause of fatigue in inflammatory bowel disease patients

2018-01 to 2021-12 | Grant
Crohn's and Colitis UK (London, GB)
Source: Self-asserted source
Gordon Moran

A new MRI based disease measure in Ulcerative Colitis – Optimisation studies in Healthy Volunteers

2018-01 to 2018-12 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Gordon Moran

Characterizing IBD Fatigue

2017-08 to 2020-07 | Award
Joan Browne Legacy (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Autologous Stem cell Transplantation In refractory Crohn’s disease - Low Intensity Therapy Evaluation (ASTIC-LITE)

2017-01 to 2022-12 | Grant
Efficacy and Mechanism Evaluation Programme (London, GB)
Source: Self-asserted source
Gordon Moran

New MRI techniques in Crohn’s Disease

2017-01 to 2020-12 | Grant
Royal Embassy of Saudi Arabia PhD Studentship (Riyadh, SA)
Source: Self-asserted source
Gordon Moran

A new MR-based Perianal Crohn’s disease activity score: A multi-centre study

2017-01 to 2018-12 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Gordon Moran

Towards Personalised Therapies for Crohn’s Disease Using Primary Intestinal Enteroids

2017-01 to 2018-12 | Grant
Wellcome Trust (London, GB)
Source: Self-asserted source
Gordon Moran

The causes of constipation. Reclassifying constipation using MRI and high resolution manometry to define mechanism of disease and target treatment.

2016-06-30 to 2019-06-29 | Grant
Medical Research Council (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.6380027
GRANT_NUMBER: MR/N026810/1
Source: Self-asserted source
Gordon Moran via DimensionsWizard

Small bowel motility quantified by cine MRI as a predictor of long term response in patients with Crohn’s disease commencing biological therapy

2016-01 to 2020-12 | Grant
Efficacy and Mechanism Evaluation Programme (London, GB)
Source: Self-asserted source
Gordon Moran

Motility in Crohn’s disease PhD Studentship

2015-09 to 2018-07 | Grant
Kuwait Foundation for the Advancement of Sciences (Kuwait, KW)
Source: Self-asserted source
Gordon Moran

Deconstructing the gut-brain axis in adult Crohn's disease using fMRI methodology

2015-08 to 2019-07 | Award
Medical Research Council (London, GB)
Source: Self-asserted source
Gordon Moran

Reduced intestinal motility in inflammatory Crohn’s disease – Optimisation studies in healthy volunteers

2015-04 to 2016-03 | Grant
Nottingham University Hospitals NHS Trust (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

An assessment of muscle function in Crohn’s disease (PI)

2015-01 to 2016-12 | Grant
Nottingham University Hospitals NHS Trust (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Anabolic resistance and abnormal muscle function across the nutritional spectrum: a pilot study in Crohn’s disease and non-alcoholic fatty-liver disease

2015-01 to 2016-12 | Grant
Core (London, GB)
Source: Self-asserted source
Gordon Moran

Pilot study to characterise the skeletal muscle metabolic response to a meal in patients with Crohn’s disease

2015-01 to 2016-12 | Grant
University Of Nottingham (Nottingham, GB)
Source: Self-asserted source
Gordon Moran

Altered appetite in Crohn’s disease: Deconstructing the enteroendocrine axis using fMRI.

2014-12-01 to 2019-03-31 | Grant
Crohn's and Colitis Foundation (New York, US)
URL: https://app.dimensions.ai/details/grant/grant.7213476
GRANT_NUMBER:

336416
Source: Self-asserted source
Gordon Moran via DimensionsWizard

Enteroendocrine cells in Crohn’s disease

2008-01 to 2011-12 | Grant
University Of Manchester (Manchester, GB)
Source: Self-asserted source
Gordon Moran

Works (50 of 117)

Items per page:
Page 1 of 3

What are the experiences of pregnancy for women living with Inflammatory Bowel Disease?

Midwifery
2025 | Journal article
DOI: 10.1016/j.midw.2024.104204
EID:

2-s2.0-85206465022

Part of ISSN: 02666138
Contributors: Janiszewski, H.; Coad, J.; Cooper, J.; Moran, G.W.; Bick, D.; Younge, L.; Greenaway, C.; Bailey, E.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study

Inflammatory Bowel Diseases
2025-03-07 | Journal article
DOI: 10.1093/ibd/izaf023
Contributors: Andrew A Plumb; Gordon Moran; Kashfia Chowdhury; Norin Ahmed; Sue Philpott; Tariq Ahmad; Stuart Bloom; Ailsa Hart; Ilan Jacobs; Alex Menys et al.
Source: check_circle
Crossref

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

The Lancet Gastroenterology and Hepatology
2024 | Journal article
DOI: 10.1016/S2468-1253(24)00034-7
EID:

2-s2.0-85186261929

Part of ISSN: 24681253
Contributors: Noor, N.M.; Lee, J.C.; Bond, S.; Dowling, F.; Brezina, B.; Patel, K.V.; Ahmad, T.; Banim, P.J.; Berrill, J.W.; Cooney, R. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Association between nutritional status assessed by body mass index and Crohn's disease phenotype: A Nation-wide analysis

Clinical Nutrition ESPEN
2024 | Journal article
DOI: 10.1016/j.clnesp.2024.09.033
EID:

2-s2.0-85207128597

Part of ISSN: 24054577
Contributors: Ndzo, J.; Vuyyuru, S.K.; Trimble, T.; Yan, K.; Figueredo, G.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

Journal of Crohn's and Colitis
2024 | Journal article
DOI: 10.1093/ecco-jcc/jjad203
EID:

2-s2.0-85195226653

Part of ISSN: 18764479 18739946
Contributors: Kapizioni, C.; Desoki, R.; Lam, D.; Balendran, K.; Al-Sulais, E.; Subramanian, S.; Rimmer, J.E.; De La Revilla Negro, J.; Pavey, H.; Pele, L. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial

BMJ Open Gastroenterology
2024 | Journal article
DOI: 10.1136/bmjgast-2023-001218
EID:

2-s2.0-85184828223

Part of ISSN: 20544774
Contributors: Jairath, V.; Zou, G.; Wang, Z.; Adsul, S.; Colombel, J.-F.; D’Haens, G.R.; Freire, M.; Moran, G.W.; Peyrin-Biroulet, L.; Sandborn, W.J. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite study

Histopathology
2024 | Journal article
DOI: 10.1111/his.15129
EID:

2-s2.0-85182453967

Part of ISSN: 13652559 03090167
Contributors: Azam, A.S.; Tsang, Y.-W.; Thirlwall, J.; Kimani, P.K.; Sah, S.; Gopalakrishnan, K.; Boyd, C.; Loughrey, M.B.; Kelly, P.J.; Boyle, D.P. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Journal of Crohn's and Colitis
2024 | Journal article
DOI: 10.1093/ecco-jcc/jjae091
EID:

2-s2.0-85206595459

Part of ISSN: 18764479 18739946
Contributors: Gordon, H.; Minozzi, S.; Kopylov, U.; Verstockt, B.; Chaparro, M.; Buskens, C.; Warusavitarne, J.; Agrawal, M.; Allocca, M.; Atreya, R. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

Journal of Crohn's and Colitis
2024 | Journal article
DOI: 10.1093/ecco-jcc/jjae089
EID:

2-s2.0-85206597956

Part of ISSN: 18764479 18739946
Contributors: Adamina, M.; Minozzi, S.; Warusavitarne, J.; Buskens, C.J.; Chaparro, M.; Verstockt, B.; Kopylov, U.; Yanai, H.; Vavricka, S.R.; Sigall-Boneh, R. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Infliximab for maintenance of medically-induced remission in Crohn's disease

Cochrane Database of Systematic Reviews
2024 | Journal article
DOI: 10.1002/14651858.CD012609.pub2
EID:

2-s2.0-85185614700

Part of ISSN: 14651858
Contributors: Gordon, M.; Sinopoulou, V.; Akobeng, A.K.; Sarian, A.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Real-world clinical effectiveness of ustekinumab in the treatment of Crohn's disease in the East Midlands UK

Frontline Gastroenterology
2024 | Journal article
DOI: 10.1136/flgastro-2024-102718
EID:

2-s2.0-85196380452

Part of ISSN: 20414145 20414137
Contributors: White, J.R.; Ahmad, S.; Ashraf, F.; Foley, S.; Din, S.; Das, R.K.; Charles, N.M.; Pinheiro, J.; Palejwala, A.; Wright, P. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Review of codelists used to define hypertension in electronic health records and development of a codelist for research

Open Heart
2024 | Journal article
DOI: 10.1136/openhrt-2024-002640
EID:

2-s2.0-85191387232

Part of ISSN: 20533624 2398595X
Contributors: Massen, G.M.; Stone, P.W.; Kwok, H.H.Y.; Jenkins, G.; Allen, R.J.; Wain, L.V.; Stewart, I.; Quint, J.K.; Thorley, A.; Duckworth, A. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial

The Lancet Gastroenterology and Hepatology
2024 | Journal article
DOI: 10.1016/S2468-1253(23)00460-0
EID:

2-s2.0-85184751876

Part of ISSN: 24681253
Contributors: Lindsay, J.O.; Hind, D.; Swaby, L.; Berntsson, H.; Bradburn, M.; Bannur C, U.; Byrne, J.; Clarke, C.; Desoysa, L.; Dickins, B. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

What do women want from their inflammatory bowel disease team during pregnancy?

Gastrointestinal Nursing
2024 | Journal article
DOI: 10.12968/gasn.2024.0019
EID:

2-s2.0-85212111452

Part of ISSN: 20522835 14795248
Contributors: Janiszewski, H.; Younge, L.; Cooper, J.; Coad, J.; Moran, G.W.; Greenaway, C.; Bailey, E.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT

2024-03 | Book
OTHER-ID:

NBK600662
Contributors: Lindsay; Hind; Swaby; Berntsson; Bradburn; Bannur C; Byrne; Clarke; Desoysa; Din et al.
Source: Self-asserted source
Gordon Moran via Europe PubMed Central

Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service.

Scandinavian journal of gastroenterology
2024-03-19 | Journal article
DOI: 10.1080/00365521.2024.2330588
PMID: 38501494
Contributors: Radford SJ; Abdul-Aema B; Tench C; Leighton P; Coad J; Moran GW
Source: Self-asserted source
Gordon Moran
grade
Preferred source (of 2)‎

Association between body mass index and age of disease onset with clinical outcomes in paediatric-onset Crohn's Disease (CD): a UK nation-wide analyses using the NIHR-IBD BioResource.

European journal of clinical nutrition
2024-03-12 | Journal article
DOI: 10.1038/s41430-024-01425-9
PMID: 38472359
Contributors: Aljilani B; Tsintzas K; Mario Siervo; BAYAN ALJILANI
Source: Self-asserted source
Gordon Moran
grade
Preferred source (of 2)‎

Prepublication abstract-only reports compared with full-text manuscripts for randomised controlled trials in inflammatory bowel disease: a systematic review.

BMJ open gastroenterology
2024-03-07 | Journal article
DOI: 10.1136/bmjgast-2023-001334
PMID: 38453251
Contributors: Vassiliki Sinopoulou; Morris Gordon; Moran GW; Egiz AMAM; Phlananthachai S; Rane A; Al-Tameemi AHA
Source: Self-asserted source
Gordon Moran
grade
Preferred source (of 2)‎

An examination of resting-state functional connectivity in patients with active Crohn’s disease

Frontiers in Neuroscience
2023 | Journal article
DOI: 10.3389/fnins.2023.1265815
EID:

2-s2.0-85180419428

Part of ISSN: 1662453X 16624548
Contributors: Thapaliya, G.; Eldeghaidy, S.; Radford, S.J.; Francis, S.T.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Association between body mass index and age of disease onset with clinical outcomes in paediatric Crohn's Disease (CD): a UK nation-wide analyses using the NIHR-IBD Bioresource

Research Square
2023 | Other
DOI: 10.21203/rs.3.rs-2748370
EID:

2-s2.0-85169714055
Contributors: Aljilani, B.; Tsintzas, K.; Siervo, M.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

BSG 2024 IBD guidelines protocol (standard operating procedures)

BMJ Open Gastroenterology
2023 | Journal article
DOI: 10.1136/bmjgast-2022-001067
EID:

2-s2.0-85148766768

Part of ISSN: 20544774
Contributors: Darie, A.-M.; Sinopoulou, V.; Ajay, V.; Kok, K.B.; Patel, K.V.; Limdi, J.; Arebi, N.; Smith, P.; Din, S.; Din, S. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Delphi consensus survey: The opinions of patients living with refractory ulcerative proctitis and the health care professionals who care for them

BMJ Open Gastroenterology
2023 | Journal article
DOI: 10.1136/bmjgast-2023-001139
EID:

2-s2.0-85161052575

Part of ISSN: 20544774
Contributors: Kyriacou, M.; Radford, S.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

In Vitro and in Vivo Assays for Testing Retinoids Effect on Intestinal Progenitors’ Lineage Commitments

Methods in Molecular Biology
2023 | Book chapter
DOI: 10.1007/978-1-0716-3076-1_5
EID:

2-s2.0-85162259371

Part of ISSN: 19406029 10643745
Contributors: Gajera, K.R.; Fair, K.L.; Moran, G.W.; Hannan, N.R.F.; Huelsken, J.; Ordóñez-Morán, P.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Infliximab for medical induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews
2023 | Journal article
DOI: 10.1002/14651858.CD012623.pub2
EID:

2-s2.0-85177455366

Part of ISSN: 14651858
Contributors: Gordon, M.; Radford, S.J.; Eldragini, M.E.A.A.; Darie, A.-M.; Sinopoulou, V.; Akobeng, A.K.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Magnetic Resonance Quantification of Muscle Phosphocreatine Resynthesis Kinetics During Exercise Recovery: An In Vivo Measure of Mitochondrial Function in Humans

Neuromethods
2023 | Book chapter
DOI: 10.1007/978-1-0716-3315-1_8
EID:

2-s2.0-85168649842

Part of ISSN: 19406045 08932336
Contributors: McGing, J.J.; Francis, S.T.; Serres, S.; Moran, G.W.; Greenhaff, P.L.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

MRI tagging of colonic chyme mixing in healthy subjects: Inter-observer variability and reliability of the measurement with time

Neurogastroenterology and Motility
2023 | Journal article
DOI: 10.1111/nmo.14610
EID:

2-s2.0-85158893009

Part of ISSN: 13652982 13501925
Contributors: Alshammari, M.T.; Alyami, A.S.; Wilkinson-Smith, V.; Spiller, R.C.; Gowland, P.; Marciani, L.; Moran, G.W.; Hoad, C.L.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

The Lancet Gastroenterology and Hepatology
2023 | Journal article
DOI: 10.1016/S2468-1253(22)00389-2
EID:

2-s2.0-85143854187

Part of ISSN: 24681253
Contributors: Liu, Z.; Le, K.; Zhou, X.; Alexander, J.L.; Lin, S.; Bewshea, C.; Chanchlani, N.; Nice, R.; McDonald, T.J.; Lamb, C.A. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease

Journal of Crohn's and Colitis
2023 | Journal article
DOI: 10.1093/ecco-jcc/jjac169
EID:

2-s2.0-85152374975

Part of ISSN: 18764479 18739946
Contributors: Ellul, P.; Schembri, J.; Vella Baldacchino, A.; Molnár, T.; Resal, T.; Allocca, M.; Furfaro, F.; Buono, A.D.; Theodoropoulou, A.; Fragaki, M. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Stakeholder-identified barriers and enablers to ultrasound implementation in inflammatory bowel disease services in the UK: a qualitative interview study

BMJ Open
2023 | Journal article
DOI: 10.1136/bmjopen-2022-067528
EID:

2-s2.0-85162758875

Part of ISSN: 20446055
Contributors: Radford, S.; Leighton, P.; Coad, J.; Moran, G.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Systematic review of sarcopenia in inflammatory bowel disease

Clinical Nutrition
2023 | Journal article
DOI: 10.1016/j.clnu.2023.05.002
EID:

2-s2.0-85163164661

Part of ISSN: 15321983 02615614
Contributors: Fatani, H.; Olaru, A.; Stevenson, R.; Alharazi, W.; Jafer, A.; Atherton, P.; Brook, M.; Moran, G.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis

Alimentary Pharmacology and Therapeutics
2023 | Journal article
DOI: 10.1111/apt.17666
EID:

2-s2.0-85168385438

Part of ISSN: 13652036 02692813
Contributors: Aruljothy, A.; Singh, S.; Narula, N.; Moran, G.W.; Vuyyuru, S.K.; Hogan, M.; Zayadi, A.; MacDonald, J.K.; Caron, B.; Danese, S. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Systematic review: Sarcopenia in paediatric inflammatory bowel disease

Clinical Nutrition ESPEN
2023 | Journal article
DOI: 10.1016/j.clnesp.2023.08.009
EID:

2-s2.0-85168356227

Part of ISSN: 24054577
Contributors: Aljilani, B.; Tsintzas, K.; Jacques, M.; Radford, S.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

Association between body mass index and age of disease onset with clinical outcomes in paediatric Crohn's Disease (CD): a UK nation-wide analyses using the NIHR-IBD Bioresource

2023-06 | Preprint
DOI: 10.21203/rs.3.rs-2748370/v1
PPR: PPR671538
Contributors: Aljilani B; Tsintzas K; Siervo M; Moran GW
Source: Self-asserted source
Gordon Moran via Europe PubMed Central

The relationship between Central Nervous System morphometry changes and key symptoms in Crohn’s disease

Brain Imaging and Behavior
2023-04 | Journal article
DOI: 10.1007/s11682-022-00742-6
Contributors: Gita Thapaliya; Sally Eldeghaidy; Michael Asghar; Jordan McGing; Shellie Radford; Susan Francis; Gordon William Moran
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Nature Communications
2022 | Journal article
DOI: 10.1038/s41467-022-28517-z
EID:

2-s2.0-85126647052

Part of ISSN: 20411723
Contributors: Lin, S.; Kennedy, N.A.; Saifuddin, A.; Sandoval, D.M.; Reynolds, C.J.; Seoane, R.C.; Kottoor, S.H.; Pieper, F.P.; Lin, K.-M.; Butler, D.K. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Clinical utility of small bowel ultrasound assessment of Crohn's disease in adults: a systematic scoping review

Frontline Gastroenterology
2022 | Journal article
DOI: 10.1136/flgastro-2021-101897
EID:

2-s2.0-85132098263

Part of ISSN: 20414145 20414137
Contributors: Radford, S.J.; Clarke, C.; Shinkins, B.; Leighton, P.; Taylor, S.; Moran, G.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Experiences of pregnancy for women living with inflammatory bowel disease: A systematic review

Gastrointestinal Nursing
2022 | Journal article
DOI: 10.12968/gasn.2022.20.8.28
EID:

2-s2.0-85146126846

Part of ISSN: 20522835 14795248
Contributors: Janiszewski, H.; Radford, S.; Coad, J.; Cooper, J.; Moran, G.; Greenaway, C.; Bailey, E.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic

Frontline Gastroenterology
2022 | Journal article
DOI: 10.1136/flgastro-2021-101805
EID:

2-s2.0-85132264254

Part of ISSN: 20414145 20414137
Contributors: Din, S.; Gaya, D.; Kammermeier, J.; Lamb, C.A.; Macdonald, J.; Moran, G.; Parkes, G.; Pollok, R.; Sebastian, S.; Segal, J. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis

Cochrane Database of Systematic Reviews
2022 | Journal article
DOI: 10.1002/14651858.CD007216.pub2
EID:

2-s2.0-85127650716

Part of ISSN: 14651858
Contributors: Gordon, M.; Sinopoulou, V.; Akobeng, A.K.; Pana, M.; Gasiea, R.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

The impact of Inflammatory Bowel Disease related fatigue on Health-Related Quality of Life: a qualitative semi-structured interview study

Journal of Research in Nursing
2022 | Journal article
DOI: 10.1177/17449871211061048
EID:

2-s2.0-85148637130

Part of ISSN: 1744988X 17449871
Contributors: Radford, S.J.; Moran, G.W.; Czuber-Dochan, W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study

Alimentary Pharmacology and Therapeutics
2022 | Journal article
DOI: 10.1111/apt.17223
EID:

2-s2.0-85139236572

Part of ISSN: 13652036 02692813
Contributors: Saifuddin, A.; Kent, A.J.; Mehta, S.J.; Hicks, L.C.; Gonzalez, H.A.; Segal, J.P.; Brookes, M.J.; Subramanian, S.; Bhala, N.; Conley, T.E. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Ultrasound use to assess Crohn’s disease in the UK: a survey of British Society of Gastroenterology Inflammatory Bowel Disease Group members

Frontline Gastroenterology
2022 | Journal article
DOI: 10.1136/flgastro-2021-102065
EID:

2-s2.0-85132827221

Part of ISSN: 20414145 20414137
Contributors: Radford, S.J.; Taylor, S.; Moran, G.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.

Gut
2022-09 | Journal article
DOI: 10.1136/gutjnl-2022-328309
PMID: 37549983
PMC: PMC10423467
Contributors: Churchhouse AM; Moffat VE; Selinger CP; Lamb CA; Thornton MJ; Penman I; Din S; BSG and Scottish IBD Surveillance Group; BSG; Scottish IBD Surveillance Group
Source: Self-asserted source
Gordon Moran via Europe PubMed Central

Acute effects of prior dietary fat ingestion on postprandial metabolic responses to protein and carbohydrate co-ingestion in overweight and obese men: A randomised crossover trial

Clinical Nutrition
2022-08 | Journal article
DOI: 10.1016/j.clnu.2022.06.022
Contributors: Andrew Wilhelmsen; Amanda Davies; Joanne Mallinson; Pardeep Pabla; Robert Jones; Elliott A. Palmer; Warwick B. Dunn; Gordon W. Moran; Francis B. Stephens; Kostas Tsintzas
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Imaging in inflammatory bowel disease: current and future perspectives

Frontline Gastroenterology
2022-08 | Journal article
DOI: 10.1136/flgastro-2022-102117
Contributors: Nader Shaban; Caroline L Hoad; Iyad Naim; Meshari Alshammari; Shellie Jean Radford; Christopher Clarke; Luca Marciani; Gordon Moran
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Establishment of a validated central reading system for ileocolonoscopy in an academic setting

Gut
2022-04 | Journal article
DOI: 10.1136/gutjnl-2021-325575
Contributors: Tim Raine; Holly Pavey; Wendi Qian; Gordon W Moran; Sreedhar Subramanian; Lizzie Swaby; Simon PL Travis; Shahida Din; Peter M Irving; James O Lindsay et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

The Lancet Gastroenterology and Hepatology
2021 | Journal article
DOI: 10.1016/S2468-1253(21)00016-9
EID:

2-s2.0-85101104815

Part of ISSN: 24681253
Contributors: Sebastian, S.; Walker, G.J.; Kennedy, N.A.; Conley, T.E.; Patel, K.V.; Subramanian, S.; Kent, A.J.; Segal, J.P.; Brookes, M.J.; Bhala, N. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

MR Measures of Small Bowel Wall T2 Are Associated With Increased Permeability

Journal of Magnetic Resonance Imaging
2021 | Journal article
DOI: 10.1002/jmri.27463
EID:

2-s2.0-85097534386

Part of ISSN: 15222586 10531807
Contributors: Scott, R.A.; Williams, H.G.; Hoad, C.L.; Alyami, A.; Ortori, C.A.; Grove, J.I.; Marciani, L.; Moran, G.W.; Spiller, R.C.; Menys, A. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier

Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies

Alimentary Pharmacology and Therapeutics
2021 | Journal article
DOI: 10.1111/apt.16465
EID:

2-s2.0-85109180296

Part of ISSN: 13652036 02692813
Contributors: McGing, J.J.; Radford, S.J.; Francis, S.T.; Serres, S.; Greenhaff, P.L.; Moran, G.W.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
grade
Preferred source (of 2)‎

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

The Lancet Gastroenterology and Hepatology
2021 | Journal article
DOI: 10.1016/S2468-1253(21)00024-8
EID:

2-s2.0-85100603177

Part of ISSN: 24681253
Contributors: Alexander, J.L.; Moran, G.W.; Gaya, D.R.; Raine, T.; Hart, A.; Kennedy, N.A.; Lindsay, J.O.; MacDonald, J.; Segal, J.P.; Sebastian, S. et al.
Source: Self-asserted source
Gordon Moran via Scopus - Elsevier
Items per page:
Page 1 of 3
How many people are using ORCID?